Showing results (61-70 of 115) with videos related to
Sort By:
Pageof 12
Journal of Affective Disorders|May 1, 1983
Plasma and erythrocyte electrolytes in affective disordersA Frazer, T A Ramsey, A Swann, et al.The American Journal of Psychiatry|January 1, 1978
Urinary 3-methoxy-4-hydroxyphenylglycol and psychiatric diagnosisS L Taube, L S Kirstein, D R Sweeney, et al.Journal of Psychiatric Research|January 1, 1987
Changes in urinary catecholamines and their metabolites in depressed patients treated with amitriptyline or imipramineC L Bowden, S Koslow, J W Maas, et al.Life Sciences|January 1, 1989
The effect of debrisoquin on MAO A and MAO B activitiesM A Javors, M E Bembenek, C L Bowden, et al.The American Journal of Psychiatry|August 1, 1979
Decreased 24-hour urinary MHPG in childhood autismJ G Young, D J Cohen, B K Caparulo, et al.Acta Psychiatrica Scandinavica|March 1, 1987
Weight loss, cortisol levels, and dexamethasone suppression in major depressive disorderR C Casper, A C Swann, P E Stokes, et al.Gynecologic and Obstetric Investigation|March 24, 1999
Fertility potential of individual sperm donorsH G Al-Inany, G A Dunselman, J C Dumoulin, et al.Archives of General Psychiatry|October 1, 1986
Cerebrospinal fluid amine metabolites. Relationships with behavioral measurements in depressed, manic, and healthy control subjectsD E Redmond, M M Katz, J W Maas, et al.Archives of General Psychiatry|September 1, 1983
CSF and urinary biogenic amines and metabolites in depression and mania. A controlled, univariate analysisS H Koslow, J W Maas, C L Bowden, et al.Clinical Pharmacology and Therapeutics|March 1, 1985
Effects of amitriptyline and imipramine on brain amine neurotransmitter metabolites in cerebrospinal fluidC L Bowden, S H Koslow, I Hanin, et al.Pageof 12